These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 16158612)
21. Gallium nitrate for acute treatment of cancer-related hypercalcemia. A randomized, double-blind comparison to calcitonin. Warrell RP; Israel R; Frisone M; Snyder T; Gaynor JJ; Bockman RS Ann Intern Med; 1988 May; 108(5):669-74. PubMed ID: 3282463 [TBL] [Abstract][Full Text] [Related]
22. Quality and Outcomes of Treatment of Hypercalcemia of Malignancy. Wright JD; Tergas AI; Ananth CV; Burke WM; Hou JY; Chen L; Neugut AI; Richards CA; Hershman DL Cancer Invest; 2015; 33(8):331-9. PubMed ID: 26068056 [TBL] [Abstract][Full Text] [Related]
23. Salmon calcitonin in the acute management of hypercalcemia. Wisneski LA Calcif Tissue Int; 1990; 46 Suppl():S26-30. PubMed ID: 2137363 [TBL] [Abstract][Full Text] [Related]
24. Combination of calcitonin and pamidronate for emergency treatment of malignant hypercalcemia. Sekine M; Takami H Oncol Rep; 1998; 5(1):197-9. PubMed ID: 9458321 [TBL] [Abstract][Full Text] [Related]
25. Hypercalcemia and gallium nitrate. Harvey HA; Almokadem SM J Support Oncol; 2004; 2(6):516-7. PubMed ID: 16329217 [No Abstract] [Full Text] [Related]
26. Hypercalcemia of malignancy: diagnosis and therapy. Fetchick DA; Mundy GR Compr Ther; 1986 Aug; 12(8):27-32. PubMed ID: 2943551 [TBL] [Abstract][Full Text] [Related]
27. Study in 25 patients shows gallium nitrate superior therapy for hypercalcemia in cancer patients. Oncology (Williston Park); 1990 Oct; 4(10):57-8. PubMed ID: 2149825 [No Abstract] [Full Text] [Related]
29. [Hypercalcemia, symptoms, differential diagnostics and treatment, or importance of calcium investigation]. Adam Z; Starý K; Kubinyi J; Zajíčková K; Řehák Z; Koukalová R; Tomíška M; Doubková M; Prášek J; Pourová E; Čermáková Z; Pour L; Krejčí M; Sandecká V; Ševčíková E; Ševčíková S; Král Z; Čermák A Vnitr Lek; 2016; 62(5):370-83. PubMed ID: 27319230 [TBL] [Abstract][Full Text] [Related]
30. Treating cancer-related hypercalcemia with gallium nitrate. Leyland-Jones B J Support Oncol; 2004; 2(6):509-16. PubMed ID: 15605917 [TBL] [Abstract][Full Text] [Related]
31. Conventional treatment of hypercalcemia of malignancy. Davidson TG Am J Health Syst Pharm; 2001 Nov; 58 Suppl 3():S8-15. PubMed ID: 11757206 [TBL] [Abstract][Full Text] [Related]
32. Gallium nitrate, "the most potent agent available," approved by FDA for hypercalcemia of cancer. Oncology (Williston Park); 1991 Mar; 5(3):76. PubMed ID: 1829948 [No Abstract] [Full Text] [Related]
33. [Bone and calcium metabolism associated with malignancy. Malignancy-associated hypercalcemia.]. Tai N; Inoue D Clin Calcium; 2018; 28(11):1503-1508. PubMed ID: 30374007 [TBL] [Abstract][Full Text] [Related]
34. Glucocorticoids and hypercalcemia. Rapado A Adv Exp Med Biol; 1984; 171():369-80. PubMed ID: 6372400 [No Abstract] [Full Text] [Related]
36. The hypercalcemia of malignancy: pathogenesis and management. Mundy GR; Martin TJ Metabolism; 1982 Dec; 31(12):1247-77. PubMed ID: 6755168 [TBL] [Abstract][Full Text] [Related]
37. Treatment of bisphosphonate-resistant hypercalcemia of malignancy with calcitonin. Dawson C; Todd AM; Walton A J Palliat Med; 2014 Oct; 17(10):1084. PubMed ID: 25265187 [No Abstract] [Full Text] [Related]
38. A case of resistant hypercalcemia of malignancy with a proposed treatment algorithm. McMahan J; Linneman T Ann Pharmacother; 2009 Sep; 43(9):1532-8. PubMed ID: 19622757 [TBL] [Abstract][Full Text] [Related]
39. The treatment of hypercalcaemia of malignancy. Heath D Clin Endocrinol (Oxf); 1991 Feb; 34(2):155-7. PubMed ID: 2022066 [No Abstract] [Full Text] [Related]
40. Hypercalcemia of malignancy remains a clinically relevant problem. Van Poznak C Cancer J; 2006; 12(1):21-3. PubMed ID: 16613658 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]